The Value of Observational Cohort Studies for Cancer Drugs

摘要

Randomized controlled trials — the gold standard for clinical drug evaluation —can’t always predict adverse events in real-world settings. For the new cancer therapies, observational cohort studies (OCSs) can help evaluate their effects in broader populations and provide valuable information for future clinical trials.